Tyra Biosciences Files Definitive Proxy Statement

Ticker: TYRA · Form: DEF 14A · Filed: Apr 18, 2025 · CIK: 1863127

Tyra Biosciences, Inc. DEF 14A Filing Summary
FieldDetail
CompanyTyra Biosciences, Inc. (TYRA)
Form TypeDEF 14A
Filed DateApr 18, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting

TL;DR

Tyra Biosciences proxy statement is out for the May 29th meeting. Vote your shares!

AI Summary

Tyra Biosciences, Inc. filed its definitive proxy statement on April 18, 2025, for its annual meeting on May 29, 2025. The company, incorporated in Delaware, is in the pharmaceutical preparations industry and is headquartered in Carlsbad, California. This filing outlines the proposals to be voted on by shareholders, including the election of directors and other corporate matters.

Why It Matters

This filing is crucial for shareholders as it details the agenda for the upcoming annual meeting, including director elections and key corporate decisions, allowing them to make informed voting decisions.

Risk Assessment

Risk Level: low — This is a routine proxy filing for an annual meeting and does not contain new material financial information or significant corporate events.

Key Players & Entities

  • Tyra Biosciences, Inc. (company) — Registrant
  • 20250418 (date) — Filing Date
  • 20250529 (date) — Meeting Date
  • Carlsbad, CA (location) — Company Headquarters

FAQ

What is the purpose of this DEF 14A filing?

This filing is a definitive proxy statement filed by Tyra Biosciences, Inc. to provide shareholders with information regarding the annual meeting of stockholders.

When is the Tyra Biosciences, Inc. annual meeting scheduled?

The annual meeting of stockholders for Tyra Biosciences, Inc. is scheduled for May 29, 2025.

What is the filing date of this proxy statement?

The definitive proxy statement was filed on April 18, 2025.

Where is Tyra Biosciences, Inc. headquartered?

Tyra Biosciences, Inc. is headquartered in Carlsbad, California.

What is the SIC code for Tyra Biosciences, Inc.?

The Standard Industrial Classification (SIC) code for Tyra Biosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 18, 2025 regarding Tyra Biosciences, Inc. (TYRA).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.